Upload
melvyn-wilson
View
213
Download
0
Embed Size (px)
Citation preview
www.bea.gov 1
Decomposing Medical-Care Expenditure Growth
Abe Dunn, Eli Liebman, and Adam Shapiro
September 11th, 2014
The views expressed in this paper are solely those of the authors and not necessarily those of Bureau of Economic Analysis.
www.bea.gov 2
Medical-Care Expenditures represents a large fraction of Personal Consumer Expenditures (PCE)
www.bea.gov
Health spending and price research suggested by CNSTAT Reports
▪ At What Price? Recommendation 6-1: BLS should select about 15 to 40 diagnoses from
the ICD (International Classification of Diseases), chosen randomly in proportion to their direct medical treatment expenditures and use information from retrospective claims databases to identify and quantify the inputs used in their treatment and to estimate their cost.
▪ Accounting for Health and Health CareRecommendation 3.4: The Bureau of Economic Analysis, working with
academic researchers (and perhaps other agencies, such as the Centers for Medicare & Medicaid Services and other parts of the Department of Health and Human Services), should collaborate on work to move incrementally toward the goal of creating disease-based expenditure accounts by attempting a “proof of concept” prototype. Using a subgroup of the population with good data coverage, the prototype would attempt to demonstrate that dollars spent in the economy on medical care can be allocated into disease categories in a fashion that yields meaningful information.
3
www.bea.gov
BEAs new satellite account will focus on medical care spending
Source: National Research Council. (2005). Beyond the Market: Designing Nonmarket Accounts for the United States. Panel to Study the Design of Nonmarket Accounts, K.G. Abraham and C. Mackie, eds. Committee on National Statistics, Division of Behavioral and Social Sciences and Education. Washington, DC: The National Academies Press.
4
Example of a Health Account
Inputs Outputs
Medical Care Spending Health status
Market labor/capital Longevity
Volunteer labor Quality of life
Time invested in own health
Other consumption items
Research and development
Quality of environment
www.bea.gov
Contribution of our work is to redefine the output of the medical care sector
For example
Output = number of patients treated for cancer
Expenditures = spending on the treatment of cancer
Price = spending per patient treated for cancer
This has implications for the accounts.
5
www.bea.gov 6
Implication 1: Spending will be reported by disease classes
Current 2010 Goods Prescription drugs $ 288,480 Services $ - Physician services $ 402,797 Paramedical services $ - Home health care $ 76,998 Medical laboratories $ 32,625 Other professional medical services $ 151,024 Hospitals $ 770,481 Total* $ 1,722,406
Proposed by Disease 2010 Infectious and parasitic $ 27,965 Neoplasms $ 127,504 Endocrine $ 120,468 Blood $ 11,830 Mental illness $ 94,881 Nervous system $ 114,945 Circulatory system $ 246,756 Respiratory system $ 108,423 Digestive system $ 99,751 Genitourinary system $ 69,179 Complications of pregnancy $ 55,499 Skin $ 23,418 Musculoskeletal system $ 191,565 Congenital anomalies $ 14,853 Certain perinatal conditions $ 5,273 Injury and poisoning $ 130,932 Symptoms and ill-defined $ 258,344 Residual codes and unclassified $ 20,819 Total Disease $ 1,722,406
Table. Household Consumption Expenditures for Medical Care Millions of Dollars
* not included - eyeglasses, other medical products, Nonprescription drugs, Therapeutic medical equipment, Nursing homes, and dental services
www.bea.gov 7
Implication 2: Redefining output also implies new price indexes.
▪ The new price indexesare the change in average expenditure per episode for each disease
▪ They reflect any shifts in services across industries that alter the cost of treating disease.
www.bea.gov 8
Implication 2: Redefining output also implies new price indexes.
▪ The new price indexesare the change in average expenditure per episode for each disease
▪ They reflect any shifts in services across industries that alter the cost of treating disease.
▪ Disease-based indexes can riseslower than traditional serviceprice indexes with shifts in treatments
www.bea.gov 9
Implication 2: Redefining output also implies new price indexes.
▪ The new price indexesare the change in average expenditure per episode for each disease
▪ They reflect any shifts in services across industries that alter the cost of treating disease.
▪ Disease-based indexes can riseslower than traditional serviceprice indexes with shifts in treatments
▪ With increases in utilization, disease-based indexes can rise faster than traditional price indexes
www.bea.gov
Selected BEA and BLS research “Producing disease-based price indexes,” Bradley, Cardenas, Ginsburg, Rozental, Velez,
Monthly Labor Review, 2010 “Alternative Price Indexes for Medical Care: Evidence from the MEPS Survey,” Aizcorbe,
Bradley (BLS), Herauf, Kane, Liebman, Pack, Rozental (BLS), BEA Working Paper, 2011 “Changing Mix of Medical Care Services: Stylized Facts and Implications for Price Indexes,”
Aizcorbe and Nestoriak, Journal of Health Economics, May 2011 “Household Consumption Expenditures for Medical Care: An Alternate Presentation,”
Aizcorbe, Liebman, Cutler, and Rosen, Survey of Current Business, June 2012 “Feasible methods to estimate disease based price indexes,” Bradley, Journal of Health
Economics, 2013 Calculating Disease-Based Medical Care Expenditure Indexes for Medicare Beneficiaries: A
Comparison of Method and Data Choices, Hall and Highfill, BEA Working Paper, 2014 Decomposing Medical-Care Expenditure Growth, Dunn, Liebman, Shapiro, BEA Working
Paper Defining Disease Episodes and the Effects on the Components of Expenditure Growth, Dunn,
Liebman, Rittmueller, and Shapiro, BEA Working Paper, 2014
10
www.bea.gov
Decomposing Medical-Care Expenditure Growth by Dunn, Liebman, and Shapiro
▪What are the sources of expenditure growth in the private health care market from 2003-07?
▪Privately insured health care – 60 percent more spending than Medicare (NHEA).
▪Use large claims data to analyzes the sources of expenditure growth.
www.bea.gov
Expenditure Decomposition
▪ What are the sources of expenditure growth?
Demographics
Prevalence
Expenditures per Episode Service Prices Service Utilization
www.bea.gov 13
Expenditure Decomposition
Exp. Per Capita
Demog. Shift Adj. Exp. Per Capita
ECI – Expenditure Per Capita Index
DECI – Demographically-adjusted Expenditure per Capita Index
DEM – Demographic Component of Expenditure Growth
www.bea.gov 14
Expenditure Decomposition
Prevalence MCE
SPI SUI
PREV – Treated Prevalence Index
MCE – Medical Care Expenditure Index (Expenditures per Episode)
SPI – Service Price Index
SUI – Service Utilization Index
Adj. Exp. Per Capita
www.bea.gov 15
Data
▪ Commercially-insured patients from the MarketScan® Data from Truven Health.
▪ Over 4 million enrollees per year.
▪ Analyze years 2003-07.
▪ Process claims using ETG Symmetry grouper from Optum.
▪ Each enrollee in the database is:1. Not in a capitated plan.
2. Has a drug benefit plan.
3. Included only if the individual is enrolled for the full year.
www.bea.gov
Sample & Weights
▪Sample Fixed MarketScan Data Contributor
▪Weights1. Weighted by region, age and sex to
match changing population demographics.
2. Weighted by region, age, and sex, fixed demographics
16
www.bea.gov
Summary Statistics
17
2003 2007Expenditure $471.5 Billion $611.6 BillionEnrollees 180,578,000 182,530,000 Expenditure per Capita (Enrollee) $2,611 $3,350Episodes 489,330,264 539,528,197 Expenditure per Episode $964 $1,134Percent Male 49.5 49.6Average Age 32.3 32.9< Age 17 27.3% 26.3%Age 18 - Age 24 9.6% 9.6%Age 25 - Age 34 14.7% 14.7%Age 35 - Age 54 36.2% 35.6%> Age 55 12.2% 13.8%
www.bea.gov
Sources of Expenditure Growth
▪ Expenditures driven by service prices and prevalence. Utilization per episode is flat.
▪ After deflating these figures, growth is primarily driven by prevalence, not expenditures per episode (i.e. disease price).
www.bea.gov 19
Decomposition
Decomposition of Aggregate Expenditure Growth, Nominal and Real
-5%
0%
5%
10%
15%
20%
25%
30%
Nominal Deflated
Demographic Shifts Treated Prevalence Service Price Index Service Utilization Index
www.bea.gov
Expenditure Growth Pattern Is Not Uniform Across Diseases.
▪ Within Disease Category Differences e.g. cardiology related conditions:
Prevalence growth is high for many early-stage illnesses.
i.e. hypertension, high cholesterol, obesity and diabetes.
Prevalence growth is relatively low for late stage illnesses.
i.e. ischemic heart disease.
www.bea.gov
Decomposition by Disease Category
Decomposition of Per Capita Expenditure Growth: Overall Expenditures and Selected Conditions
2%
2%
4%
7%
3%
3%
29%
1%
11%
4%
12%
10%
14%
19%
17%
15%
14%
14%
11%
1%
0%
-8%
2%
-1%
-10% 0% 10% 20% 30% 40% 50% 60%
Preventative (2.3%)
Gyneco. (7.1%)
Gastro. (9.1%)
Cardio. (12.2%)
Ortho. (16.6%)
Overall (100%)
Dis
ease
Cat
ego
ry (
2003
Sp
end
ing
Sh
are)
Demographic Shifts Prevalence Service Prices Service Utilization
www.bea.gov
2003 Expenditure
2007 Expenditure
2003 Share of Total
Share of Expenditure
per Capita per Capita Expenditure Growth ECI Dem DECI PREV MCE SPI SUIOrthopedics & Rheumatology $434 $579 16.6% 19.6% 1.33 1.03 1.30 1.12 1.17 1.14 1.02
Cardiology $317 $373 12.2% 7.5% 1.18 1.07 1.11 1.04 1.06 1.15 0.92Gastroenterology $238 $317 9.1% 10.6% 1.33 1.04 1.29 1.11 1.17 1.17 1.00
Gynecology $185 $228 7.1% 5.8% 1.23 1.02 1.22 1.01 1.20 1.19 1.01Endocrinology $177 $248 6.8% 9.5% 1.40 1.05 1.34 1.27 1.07 1.16 0.93
Otolaryngology $165 $188 6.3% 3.1% 1.14 1.00 1.14 1.03 1.11 1.12 0.99Neurology $151 $201 5.8% 6.7% 1.33 1.03 1.30 1.10 1.19 1.20 0.99Psychiatry $124 $150 4.8% 3.4% 1.20 1.04 1.16 1.01 1.16 1.20 0.97
Pulmonology $120 $151 4.6% 4.2% 1.26 1.00 1.26 1.13 1.12 1.13 0.99Dermatology $118 $152 4.5% 4.7% 1.29 1.02 1.28 1.08 1.18 1.15 1.02
Obstetrics $112 $140 4.3% 3.7% 1.25 0.99 1.26 1.08 1.17 1.15 1.02Urology $96 $122 3.7% 3.5% 1.27 1.05 1.22 1.12 1.11 1.13 0.98
Hematology $65 $86 2.5% 2.8% 1.32 1.04 1.28 1.11 1.15 1.21 0.95Hepatology $61 $70 2.3% 1.2% 1.15 1.03 1.12 0.99 1.12 1.17 0.95
Preventive & Administrative $60 $99 2.3% 5.2% 1.64 1.02 1.62 1.29 1.26 1.14 1.11Ophthalmology $43 $53 1.6% 1.4% 1.25 1.06 1.19 1.13 1.05 1.08 0.98
Nephrology $36 $50 1.4% 1.9% 1.39 1.06 1.33 1.49 0.90 0.91 1.00Infectious diseases $35 $49 1.3% 1.9% 1.41 1.03 1.38 1.15 1.18 1.12 1.06
Neonatology $28 $40 1.1% 1.6% 1.43 1.12 1.32 1.14 1.17 1.13 1.03Isolated signs & symptoms $19 $21 0.7% 0.3% 1.12 1.01 1.11 1.00 1.11 1.10 1.02
Late effects, environmental trauma $14 $18 0.5% 0.6% 1.30 1.02 1.27 0.96 1.34 1.29 1.04Chemical dependency $13 $18 0.5% 0.7% 1.42 1.00 1.41 1.38 1.06 1.09 0.98
Total $2,611 $3,350 100% 100% 1.28 1.03 1.25 1.10 1.14 1.15 0.99
2007 Indexes
Decomposition by Disease Category
www.bea.gov
Cardiology
2003 Expenditure
2007 Expenditure
per Capita per Capita ECI DEM DECI PREV MCE SPI SUIIschemic heart disease 1 $55 $54 0.98 1.07 0.91 0.95 0.96 1.14 0.86
Hypertension 1 $48 $64 1.33 1.06 1.27 1.14 1.11 1.13 1.01Diabetes 1 $43 $68 1.58 1.09 1.48 1.28 1.16 1.17 1.01
Ischemic heart disease 2 $30 $32 1.07 1.08 0.99 1.09 0.91 1.09 0.84Hyperlipidemia, other 1 $26 $37 1.43 1.08 1.35 1.29 1.05 1.16 0.95
2007 Indexes
www.bea.gov
Orthopedics and Rheumatology
ECI DEM DECI PREV MCE SPI SUIJoint degeneration, localized - back 1 $42 $56 1.32 1.03 1.29 1.15 1.12 1.18 0.98
Joint derangement - knee & lower leg 2 $30 $37 1.24 1.02 1.22 1.09 1.12 1.07 1.05Joint degeneration, localized - knee & lower leg 1 $25 $43 1.68 1.12 1.56 1.24 1.26 1.15 1.09
Joint degeneration, localized - neck 1 $22 $28 1.26 1.02 1.23 1.14 1.08 1.14 0.98Joint degeneration, localized - back 2 $18 $26 1.43 1.06 1.37 1.24 1.11 1.17 0.96
2007 Indexes2007 Expenditure Per Capita
2003 Expenditure per Capita
www.bea.gov
Gastroenterology
2003 Expenditure
2007 Expenditure
per Capita per Capita ECI DEM DECI PREV MCE SPI SUIInflammation of esophagus 1 $27 $29 1.09 1.02 1.07 1.06 1.01 1.12 0.92
Gastroenterology diseases signs & symptoms 1 $23 $33 1.41 1.03 1.39 1.16 1.20 1.15 1.05Non-malignant neoplasm of intestines & abdomen 1 $20 $27 1.34 1.08 1.26 1.16 1.08 1.08 1.02
Hernias, except hiatal 1 $10 $12 1.19 1.03 1.16 1.02 1.14 1.19 0.96Appendicitis 1 $9 $12 1.41 0.99 1.42 1.15 1.24 1.20 1.02
2007 Indexes
www.bea.gov
Neoplasms
2003 Expenditure
2007 Expenditure
per Capita per Capita ECI DEM DECI PREV MCE SPI SUIMalignant $50 $77 1.53 1.06 1.47 1.07 1.37 1.27 1.33
Non-Malignant $11 $12 1.04 1.01 1.03 0.85 1.21 1.18 1.03Malignant $16 $21 1.27 1.09 1.17 0.95 1.23 1.28 1.40
Non-Malignant $1 $1 1.12 1.03 1.09 1.04 1.05 0.97 1.08Malignant $13 $21 1.55 1.09 1.46 0.97 1.51 1.45 0.99
Non-Malignant $2 $3 1.73 1.09 1.64 1.52 1.08 1.06 1.04Malignant $13 $20 1.55 1.15 1.40 1.09 1.29 1.17 1.07
Non-Malignant $4 $6 1.56 1.13 1.43 1.06 1.35 1.15 1.19Malignant $10 $14 1.35 1.08 1.28 1.08 1.18 1.11 1.04
Non-Malignant $15 $19 1.27 1.03 1.25 1.13 1.10 1.11 1.00Malignant $162 $240 1.48 1.08 1.40 1.08 1.30 1.25 1.05
Non-Malignant $107 $133 1.24 1.03 1.21 1.11 1.11 1.15 0.98All other diseases $2,247 $2,856 1.27 1.03 1.24 1.10 1.13 1.15 0.99
Neoplasm of prostate
Neoplasm of skin, major
All neoplasms
2007 Indexes
Neoplasm of breast
Neoplasm of pulmonary system
Neoplasm of rectum or anus
www.bea.gov
Conclusion
▪ Over the 2003-07 period for the commercial sector: Expenditures primarily driven by service price
growth, but service price growth does not greatly exceed overall inflation.
Treated prevalence growth plays an important role in real growth in output.
Tends in the components of expenditure growth are disease-specific.
www.bea.gov
BEA Health Account
▪ Release survey article of Health Care Satellite Account around December of this year. http://www.bea.gov/national/health_care_satellite_account.htm
▪ Account will incorporate expenditure estimates from full population, not just commercial sector.
▪ Account will report estimates over a longer horizon 2000 to 2010.
28
www.bea.gov
Future Satellite Account Work
▪ New release in 2015 with 2011 and 2012 estimates
▪ Creating a longer time series and current estimates
▪ Evaluate the impact on Industry accounts
▪ Evaluate the impact Income accounts
▪ Evaluate Quality Adjustment
▪ Continue to evaluate data sources – MEPS, MarketScan®, Medicare, along with Medicaid and others.
▪ Integrate/incorporate/compare BEA/HSA with BLS PPI or CPI disease-based indexes (once created)
29